title: Different glycosylation pattern of human IgG1 and IgG3 antibodies isolated from transiently as well as permanently transfected cell lines.
abstract: The effector functions of IgG depend on the presence of carbohydrates attached to asparagine 297 in the Fc-portion. In this report, glycosylation profiles of recombinant wild-type and mutant IgG1 and IgG3 antibodies produced from three cell lines were analysed using LC-ESI-Orbitrap. Clear differences were detected between IgG1 and IgG3 glycoforms, where IgG1 generally contained fucosylated glycoforms, whilst IgG3 mainly were non-fucosylated. When using NS-0 and J558L cells for permanent transfection, IgG1 wt glycoforms differed between the two cell lines, whilst IgG3 wt glycoforms did not. Transiently transfected HEK 293E cells were used to produce IgG1 and IgG3 wt and mutants, affecting complement activation. Cell supernatants were harvested at early and late time points and analysed separately. IgGs harvested late showed simpler and less developed glycosylation structure compared to those harvested early. The IgG harvested early was slightly more effective in complement activation than those harvested late, whilst the antibody-dependent cell-mediated cytotoxicity was unaltered. Generally, the glycosylation pattern of the mutants tested, including a hinge truncate mutant of IgG3, did not differ significantly from the wild-type IgGs. The striking difference in glycosylation pattern of IgG1 compared to IgG3 therefore appears not to be due to the long hinge region of IgG3 (62 amino acids) relative to the IgG1 hinge region (15 amino acids). Furthermore, mutation variants at or near the C1q binding site showed similar glycosylation structure and difference in their complement activation activity observed earlier is thus most likely due to differences in protein structure only.
authors.affiliation: Department of Bacteriology & Immunology, Norwegian Institute of Public Health, 0403 Oslo, Norway. Anne.Cathrine.Vestrheim@fhi.no
authors.forename: A C
authors.initials: AC
authors.lastname: Vestrheim
authors.forename: A
authors.initials: A
authors.lastname: Moen
authors.forename: W
authors.initials: W
authors.lastname: Egge-Jacobsen
authors.forename: D B
authors.initials: DB
authors.lastname: Bratlie
authors.forename: T E
authors.initials: TE
authors.lastname: Michaelsen
mesh_terms: D000818:Animals; D000906:Antibodies / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D001665:Binding Sites / Q000235:genetics; D045744:Cell Line, Tumor; D005643:Fucose / Q000378:metabolism; D006023:Glycoproteins / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D006031:Glycosylation; D057809:HEK293 Cells; D006801:Humans; D007074:Immunoglobulin G / Q000235:genetics / Q000276:immunology* / Q000302:isolation & purification / Q000378:metabolism; D013058:Mass Spectrometry; D009154:Mutation; D011994:Recombinant Proteins / Q000276:immunology* / Q000378:metabolism; D013997:Time Factors; D014162:Transfection
chemical_list: D000906:Antibodies; D006023:Glycoproteins; D007074:Immunoglobulin G; D011994:Recombinant Proteins; D005643:Fucose